[go: up one dir, main page]

HK1046428A1 - 1型人类免疫缺乏病毒(hiv-1)亚型间的基因组及其应用 - Google Patents

1型人类免疫缺乏病毒(hiv-1)亚型间的基因组及其应用 Download PDF

Info

Publication number
HK1046428A1
HK1046428A1 HK02107615A HK02107615A HK1046428A1 HK 1046428 A1 HK1046428 A1 HK 1046428A1 HK 02107615 A HK02107615 A HK 02107615A HK 02107615 A HK02107615 A HK 02107615A HK 1046428 A1 HK1046428 A1 HK 1046428A1
Authority
HK
Hong Kong
Prior art keywords
polypeptide
nucleic acid
acid sequence
encoded
nucleotide
Prior art date
Application number
HK02107615A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1046428B (zh
Inventor
Yiming Shao
Ralf Wagner
Hans Wolf
Marcus Graf
Original Assignee
Geneart Ag
Yiming Shao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geneart Ag, Yiming Shao filed Critical Geneart Ag
Publication of HK1046428A1 publication Critical patent/HK1046428A1/zh
Publication of HK1046428B publication Critical patent/HK1046428B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK02107615.8A 1999-11-16 2000-11-16 1型人类免疫缺乏病毒(hiv-1)亚型间的基因组及其应用 HK1046428B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19955089.1 1999-11-16
DE19955089 1999-11-16
PCT/DE2000/004073 WO2001036614A2 (de) 1999-11-16 2000-11-16 Das genom des hiv-1 intersubtyps (c/b') und seine anwendungen

Publications (2)

Publication Number Publication Date
HK1046428A1 true HK1046428A1 (zh) 2003-01-10
HK1046428B HK1046428B (zh) 2008-08-15

Family

ID=

Also Published As

Publication number Publication date
DE10056747A1 (de) 2001-05-31
AU2350401A (en) 2001-05-30
EP1240333A2 (de) 2002-09-18
DE50015096D1 (de) 2008-05-21
WO2001036614A3 (de) 2002-02-28
US7323557B2 (en) 2008-01-29
ZA200204047B (en) 2002-12-20
CN1423698A (zh) 2003-06-11
BR0015607A (pt) 2002-07-30
AP1674A (en) 2006-10-30
AP2002002508A0 (en) 2002-06-30
CN101586106B (zh) 2015-04-01
ATE391785T1 (de) 2008-04-15
US20070003572A1 (en) 2007-01-04
OA12156A (en) 2006-05-08
WO2001036614A2 (de) 2001-05-25
AU784635B2 (en) 2006-05-18
CA2391560A1 (en) 2001-05-25
CN101586106A (zh) 2009-11-25
US7332588B1 (en) 2008-02-19
EP1240333B1 (de) 2008-04-09
ES2303513T3 (es) 2008-08-16

Similar Documents

Publication Publication Date Title
US7323557B2 (en) Genome of the HIV-1 inter-subtype (C/B') and use thereof
KR100571479B1 (ko) Hiv에 대한 폴리엔브백신으로서 재조합 백시니아벡터의 혼합물
JP6165612B2 (ja) コンセンサス／先祖免疫原
JP5033303B2 (ja) 抗原性ｃ型ｈｉｖポリペプチドをコードするポリヌクレオチド、ポリペプチドおよびそれらの使用
JP3967374B2 (ja) 同調的インビボ遺伝子発現
US20050123555A1 (en) Alphavirus vectors and virosomes with modified HIV genes for use as vaccines
JP2001512308A (ja) 合成ｈｉｖ ｇａｇ遺伝子
Bourgault et al. Simian immunodeficiency virus as a model for vaccination against HIV. Induction in rhesus macaques of GAG-or NEF-specific cytotoxic T lymphocytes by lipopeptides.
JP2009082136A (ja) 抗原性ｂ型ｈｉｖポリペプチドおよび／または抗原性ｃ型ｈｉｖポリペプチドをコードするポリヌクレオチド、それらのポリペプチドおよびそれらの使用
US7122180B2 (en) DNA vectors containing mutated HIV proviruses
CZ266798A3 (cs) Syntetický polynukleotid obsahující DNA sekvence kódující HIV proteiny
JP2013146270A (ja) 抗原性ｂ型ｈｉｖポリペプチドをコードするポリヌクレオチド、そのポリペプチドおよびそれらの使用
MXPA04002631A (es) Vacunas de adn optimizadas por codon gag-vih.
Mills et al. HIV p24-specific helper T cell clones from immunized primates recognize highly conserved regions of HIV-1.
VAN EENDENBURG et al. Cell-mediated immune proliferative responses to HIV-1 of chimpanzees vaccinated with different vaccinia recombinant viruses
WO2002003917A2 (en) Alphavirus vectors and virosomes with modified hiv genes for use as vaccines
Young et al. Elicitation of immunity to HIV type 1 Gag is determined by Gag structure
HK1046428B (zh) 1型人类免疫缺乏病毒(hiv-1)亚型间的基因组及其应用
HU et al. Immune Responses to SIV mne Envelope Glycoproteins Protect Macaques from Homologous SIV Infection
EP1444350B1 (en) Hiv-1 subtype isolate regulatory/accessory genes, and modifications and derivatives thereof
EP1309617B1 (en) Process for the selection of hiv-1 subtype c isolates, selected hiv-1 subtype isolates, their genes and modifications and derivatives thereof
Malkevitch et al. Evaluation of combination DNA/replication-competent Ad-SIV recombinant immunization regimens in rhesus macaques
EP0276591A2 (fr) Vaccin constitué par un vecteur viral et ADN recombinant codant notamment pour la protéine p25 du virus agent causal du S.I.D.A.
JP2017512499A (ja) モザイクｈｉｖ−１配列およびその使用
KR101067231B1 (ko) Ｈｉｖ-ｇａｇ 코돈-최적화된 ｄｎａ 백신

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20201115